Works matching DE "BAXTER Hyland Immuno (Company)"

An approach to study the viral safety of plasma-derived products in previously treated, non-infected patients.

Published in:

Haemophilia, 2001, v. 7, n. 4, p. 360, doi. 10.1046/j.1365-2516.2001.00522.x

By:

• Berntorp, E.;
• Petrini, P.;
• Dockter, G.;
• Tengborn, L.;
• Wendisch, I.;
• Eberl, W.;
• Aumann, V.;
• Frade, G.;
• Seliger, I.;
• Engl, W.;
• Ehrlich, H.

Publication type:

Article